Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Shlofmitz

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
JACC. Cardiovascular Interventions|February 19, 2021
Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-AnalysisMarco Valgimigli, Roxana Mehran, Anna Franzone, et al.
European Heart Journal|October 21, 2020
Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACSUsman Baber, George Dangas, Dominick Joseph Angiolillo, et al.
JACC. Cardiovascular Interventions|October 6, 2022
Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass IndexVijay Kunadian, Usman Baber, Carlo A Pivato, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
JACC. Cardiovascular Interventions|February 19, 2021
Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-AnalysisMarco Valgimigli, Roxana Mehran, Anna Franzone, et al.
European Heart Journal|October 21, 2020
Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACSUsman Baber, George Dangas, Dominick Joseph Angiolillo, et al.
JACC. Cardiovascular Interventions|October 6, 2022
Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass IndexVijay Kunadian, Usman Baber, Carlo A Pivato, et al.
Pageof 8